Krsnaa Diagnostics Limited (KRSNAA)

Price650.25 -2.35 (-0.36%)52 Week High699.70
ISININE08LI0102052 Week Low353.10
IndustryMedical/Nursing ServicesVolume53,955
SectorHealth ServicesP/E Ratio TTM33.30
Market Cap20.4 B1 Year Beta-0.62
Technical Rating of

Krsnaa Diagnostics Limited (KRSNAA) logo

Krsnaa Diagnostics Limited (KRSNAA) is a diagnostic imaging and pathology services provider based in India. It was founded in 2009 by Dr. Ashish Jain and is headquartered in Pune, Maharashtra. The company has a network of over 100 diagnostic centers across India.

KRSNAA’s services include:

  • Radiology: Krsnaa Diagnostics offers a range of radiology services, including X-rays, CT scans, and MRI scans.
  • Pathology: Krsnaa Diagnostics offers a range of pathology services, including blood tests, urine tests, and stool tests.
  • Teleradiology: Krsnaa Diagnostics also offers teleradiology services, which allow radiologists to interpret images from remote locations.

KRSNAA is a well-managed company with a strong track record of financial performance. The company has been profitable for over 10 years and has a strong balance sheet. KRSNAA is also one of the leading diagnostic imaging and pathology services providers in India.

Here are some of the key aspects of Krsnaa Diagnostics Limited (KRSNAA):

  • Products and services: Krsnaa Diagnostics offers a range of radiology and pathology services.
  • Customers: Krsnaa Diagnostics’s customers include a wide range of individuals, families, and businesses.
  • Financial performance: Krsnaa Diagnostics has been profitable for over 10 years and has a strong balance sheet.
  • Market share: Krsnaa Diagnostics is one of the leading diagnostic imaging and pathology services providers in India. It has a market share of over 5% of the Indian diagnostic imaging and pathology services market.
  • Growth potential: Krsnaa Diagnostics is well-positioned to continue to grow its business in the coming years, due to the increasing demand for diagnostic imaging and pathology services in India.

However, there are also some risks associated with investing in KRSNAA. These risks include:

  • Competition: Krsnaa Diagnostics faces competition from other Indian and international diagnostic imaging and pathology services providers.
  • Regulation: The diagnostic imaging and pathology services industry is regulated by the government of India. This regulation could impact KRSNAA’s business in the future.
  • Technology: The diagnostic imaging and pathology services industry is constantly evolving. Krsnaa Diagnostics needs to be able to keep up with this evolution in order to remain competitive.
  • Changing consumer preferences: Consumer preferences for diagnostic imaging and pathology services could change in the future. This could impact KRSNAA’s business.

Overall, Krsnaa Diagnostics Limited (KRSNAA) is a well-managed company with a strong track record of financial performance. The company is also one of the leading diagnostic imaging and pathology services providers in India. However, there are some risks associated with investing in KRSNAA, such as competition, regulation, and technology.

          

Krsnaa Diagnostics Limited (KRSNAA) Chart

Technical Analysis of Krsnaa Diagnostics Limited (KRSNAA)

Moving Averages

PeriodSimpleExponential
MA 5650.93651.33
MA 10654.40650.65
MA 20646.91635.65
MA 30608.88619.01
MA 50567.36595.86
MA 100561.94562.76
MA 200502.03538.09

Moving Average Rating

Technical Indicators

NameValueNameValue
Aroon Up (14)14.29Aroon Down (14)57.14
MACD Level (12, 26)23.41MACD Signal (12, 26)28.66
Relative Strength Index (7)52.88Relative Strength Index (14)59.83
Stochastic %D (14 3 3)43.76Stochastic %K (14 3 3)42.15
Stochastic RSI Fast (3, 3, 14, 14)8.22Stochastic RSI Slow (3, 3, 14, 14)9.12
Bollinger Upper Band (20)705.20Bollinger Lower Band (20)588.63
Keltner Channels Upper Band (20)691.47Keltner Channels Lower Band (20)579.84
Donchian Channels Upper Band (20)699.70Donchian Channels Lower Band (20)569.20
Ichimoku Conversion Line (9, 26, 52, 26)656.50Ichimoku Base Line (9, 26, 52, 26)590.90
Ichimoku Leading Span A (9, 26, 52, 26)514.44Ichimoku Leading Span B (9, 26, 52, 26)528.80
Positive Directional Indicator (14)23.72Negative Directional Indicator (14)14.68
Volume Weighted Average Price649.53Volume Weighted Moving Average 20638.51

Oscillator Rating

Oscillators

Awesome Oscillator55.49
Ultimate Oscillator (7,14,28)45.71
Money Flow (14)44.03
Chaikin Money Flow (20)0.06
Commodity Channel Index (20)6.48
Bull Bear Power3.61

High / Low

1 Month699.70568.10
3 Month699.70448.60
6 Month699.70435.05
52 Week699.70353.10
All Time1,099.70353.10

Volume

Volume53,955.00
Average 10 D110,562.10
Average 30 D176.9 T
Average 60 D164.2 T
Average 90 D144,356.49

Change/Volatility

Change-2.35 (-0.36%)
Change 1W-2.45 (-0.38%)
Change 1M25.25 (4.04%)
Volatility2.58
Volatility W3.56

Performance

Yesterday41.05
Weekly-2.90
Monthly13.91
3 Month11.36
6 Month45.42
Yearly32.43
5 Year-35.33
All Time-35.33

Misc.

Average Day Range (14)29.29
Average Directional Index (14)36.69
Average True Range (14)27.65
Williams Percent Range (14)-58.38
Rate Of Change (9)-4.66
Hull Moving Average (9)650.53
Momentum (10)-26.30
Parabolic SAR680.08

PIVOT POINTS of Krsnaa Diagnostics Limited (KRSNAA)

NameS3S2S1Pivot PointsR1R2R3
Classic268.23425.13525.07582.03681.97738.93895.83
Fibonacci425.13485.07522.10582.03641.97679.00738.93
Camarilla581.85596.24610.62582.03639.38653.76668.15
Woodie's394.55438.33551.45595.23708.35752.13865.25
DeMark's - - 553.55596.28710.45 - -

Financial Analysis of Krsnaa Diagnostics Limited (KRSNAA)

Income Statement

Basic EPS (FY)19.78
Basic EPS (TTM)19.92
EBITDA (Annual YoY Growth)-6.23
EBITDA (Quarterly QoQ Growth)-9.05
EBITDA (Quarterly YoY Growth)12.88
EBITDA (TTM)1.3 B
EBITDA (TTM YoY Growth)6.90
EPS Diluted (Annual YoY Growth)-15.71
EPS Diluted (FY)19.29
EPS Diluted (MRQ)4.70
EPS Diluted (Quarterly QoQ Growth)-23.13
EPS Diluted (Quarterly YoY Growth)0.22
EPS Diluted (TTM)19.53
EPS Diluted (TTM YoY Growth)-3.27
EPS Forecast (MRQ)7.40
Free Cash Flow (Annual YoY Growth)-1,918.08
Free Cash Flow Margin (FY)-12.37
Gross Profit (Annual YoY Growth)5.38
Gross Profit (FY)1.8 B
Gross Profit (MRQ)557.7 M
Gross Profit (Quarterly QoQ Growth)-0.12
Gross Profit (Quarterly YoY Growth)24.11
Gross Profit (TTM YoY Growth)21.41
Last Year Revenue (FY)4.9 B
Revenue (Annual YoY Growth)6.95
Revenue per Employee (FY)1.9 M
Revenue (Quarterly QoQ Growth)4.77
Revenue (Quarterly YoY Growth)23.68
Revenue (TTM YoY Growth)17.90
Net Income (Annual YoY Growth)-9.18
Net Income (FY)621.1 M
Net Income (Quarterly QoQ Growth)-22.60
Net Income (Quarterly YoY Growth)3.01
Net Income (TTM YoY Growth)2.51
Total Revenue (FY)4.9 B

Valuation

Enterprise Value/EBITDA (TTM)16.23
Number of Employees2,562.00
Number of Shareholders67,116.00
Shares Float14.7 M
Price to Book (FY)2.76
Price to Earnings Ratio (TTM)33.30
Price to Revenue Ratio (TTM)4.10
Price to Sales (FY)4.30
Total Shares Outstanding31.4 M
Selling & Admin expenses Ratio (FY)22.17
Selling & Admin expenses Ratio (TTM)28.32

Balance Sheet

Total Assets (Annual YoY Growth)2.79
Total Debt (Annual YoY Growth)-20.76
Total Liabilities (FY)1.7 B
Cash & Equivalents (FY)227.2 M
Cash and short term investments (FY)1.1 B

Operating Metrics

Dividends

Dividend Yield Forward0.42
Dividends Paid (FY)-78,490,000.00
Dividends per share (Annual YoY Growth)10.00
Dividends per Share (FY)2.75

Margins

Net Margin (FY)12.75
Net Margin (TTM)12.17
Gross Margin (FY)36.65
Gross Margin (TTM)41.69
Operating Margin (FY)14.42
Operating Margin (TTM)13.37
Pretax Margin (TTM)15.46

Related Companies (Peers) to Krsnaa Diagnostics Limited (KRSNAA)

Price2,339.60 -51.35 (-2.15%)52 Week High2,750.00
ISININE600L0102452 Week Low1,762.05
IndustryMedical/Nursing ServicesVolume177.9 T
SectorHealth ServicesP/E Ratio TTM73.86
Market Cap199.4 B1 Year Beta0.54
Technical Rating of
Dr. Lal Path Labs Ltd. (LALPATHLAB) is an Indian diagnostic laboratory chain. It was founded in 1983 and is headquartered in Delhi, India. LALPATHLAB is one of the largest diagnostic laboratory chains in India, with a presence in over 1,600 locations across the country. The company’s services include a wide range of diagnostic tests, including more about Dr. Lal Path Labs Ltd. (LALPATHLAB)

Price83.95 -1.05 (-1.24%)52 Week High108.00
ISININE947I0101752 Week Low55.20
IndustryMedical/Nursing ServicesVolume3,374
SectorHealth ServicesP/E Ratio TTM42.72
Market Cap1.7 B1 Year Beta0.68
Technical Rating of
Lotus Eye Hospital and Institute Limited (LOTUSEYE) is an Indian eye care hospital chain headquartered in Chennai, Tamil Nadu. It was founded in 1986 by Dr. V. G. Raman. LOTUSEYE is one of the leading eye care hospital chains in India. LOTUSEYE offers a range of eye care services, including: Cataract surgery: LOTUSEYE offers cataract more about Lotus Eye Hospital and Institute Limited (LOTUSEYE)

Price137.10 -2.55 (-1.83%)52 Week High195.00
ISININE0CG60101652 Week Low76.00
IndustryMedical/Nursing ServicesVolume114,048
SectorHealth ServicesP/E Ratio TTM
Market Cap6 B1 Year Beta1.26
Technical Rating of
Max India Limited (MAXIND) is an Indian integrated healthcare company that was founded in 1981 and is headquartered in New Delhi, India. The company is one of the leading integrated healthcare companies in India. MAXIND has a strong focus on the Indian market. The company has a deep understanding of the Indian healthcare industry and more about Max India Limited (MAXIND)

Price1,417.75 -3.15 (-0.22%)52 Week High1,791.20
ISININE112L0102052 Week Low1,171.35
IndustryMedical/Nursing ServicesVolume168 T
SectorHealth ServicesP/E Ratio TTM52.67
Market Cap72.7 B1 Year Beta0.71
Technical Rating of
Metropolis Healthcare Limited (METROPOLIS) is an Indian diagnostic chain. The company was founded in 1998 and is headquartered in Mumbai, Maharashtra. Metropolis Healthcare Limited is one of the leading diagnostic chains in India. The company has a strong focus on the Indian market. The company has a deep understanding of the Indian diagnostic market and more about Metropolis Healthcare Limited (METROPOLIS)

Price562.45 -6.35 (-1.12%)52 Week High768.25
ISININE594H0101952 Week Low415.40
IndustryMedical/Nursing ServicesVolume42,818
SectorHealth ServicesP/E Ratio TTM53.85
Market Cap30.1 B1 Year Beta0.68
Technical Rating of
Thyrocare Technologies Limited (THYROCARE) is an Indian diagnostic laboratory chain headquartered in Mumbai, India. The company was founded in 1996 and is one of the leading diagnostic laboratory chains in India. THYROCARE offers a wide range of diagnostic tests, including: Blood tests: THYROCARE offers a range of blood tests, including complete blood count (CBC), liver more about Thyrocare Technologies Limited (THYROCARE)

Price455.60 -10.05 (-2.16%)52 Week High529.00
ISININE043W0102452 Week Low349.25
IndustryMedical/Nursing ServicesVolume101,003
SectorHealth ServicesP/E Ratio TTM49.96
Market Cap47.5 B1 Year Beta0.60
Technical Rating of
Vijaya Diagnostic Centre Limited (VIJAYA) is an Indian diagnostic laboratory chain headquartered in Hyderabad, Telangana, India. It was founded in 1981 by Dr. K. Vijayanand. VIJAYA is a leading diagnostic laboratory chain in India. It has a network of over 200 laboratories across India. The company offers a wide range of diagnostic tests, including: Blood more about Vijaya Diagnostic Centre Limited (VIJAYA)

Krsnaa Diagnostics Limited (KRSNAA) Related Indices

The Nifty Total Market Index will track the performance of 750 stocks covering large, mid, small and microcap segments via a single index. All stocks that are part of Nifty 500 index and Nifty Microcap 250 index form part of the Nifty Total Market index. Stock’s weight is based on its free-float market capitalization. more about Nifty Total Market

The Nifty Microcap 250 index aims to track the performance of microcap stocks listed or permitted to trade on NSE. The index includes the top 250 companies beyond the Nifty 500 index constituents, selected based on their average full market capitalization. A stock’s weight is based on its free-float market capitalization. more about Nifty Microcap 250

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock Sectors
Stock Industries